Release of the 2025 National Survey on Drug Use and Health: Using Data to Drive the Great American Recovery
Impact on your practice
This epidemiological data release informs national mental health policy and funding priorities but does not directly change therapist practice, billing, or licensing. It may influence future funding allocations and grant opportunities.
Key facts
2025 National Survey on Drug Use and Health data released by SAMHSA
Tracks substance use, addiction, and mental health prevalence nationally
Over 1.5 million deaths from overdose and suicide in past two decades
Data used to inform federal funding and policy priorities
Therapy Companion analysis
This epidemiological snapshot will shape your referral patterns, patient demographics, and funding landscape over the next 2-3 years, but does not immediately change your billing codes, documentation requirements, or licensure. However, the data reveals critical practice implications: nearly 45 million Americans meet substance use disorder criteria (15.3% of the population), while 20.6% of adults have any mental illness and 6.9% have serious mental illness. For your practice, this means demand for services will remain high, particularly among young adults aged 18-25, where serious mental illness reaches 12.1% and major depressive episodes hit 14.2%. The data also shows adolescent mental health improved from 2021-2025 across all key indicators—depression, suicidality, and self-harm all declined—which may reduce crisis referrals from schools but increase routine outpatient volume as prevention efforts succeed. Substance use disorder prevalence remains stable overall, though marijuana use disorder (19.3 million people) now exceeds opioid use disorder (4.0 million), signaling a shift in your patient population's primary substance concerns. If you work in addiction treatment or co-occurring disorders, expect continued demand; if you're in general mental health, prepare for higher volumes of anxiety and depression cases, especially among younger cohorts. Federal funding decisions over the next 18-24 months will be informed by this data, meaning grant opportunities, SAMHSA block grants to states, and Medicaid expansion priorities will likely emphasize young adult mental health, substance use prevention, and suicide prevention—areas where you can position your practice for contract growth.
Background
SAMHSA releases the National Survey on Drug Use and Health annually to inform federal policy and funding allocation. This 2025 release is notable because it marks the first time since 2020 that five consecutive years of trend data are available, allowing policymakers to assess progress and identify gaps. The Trump administration's 'Make America Healthy Again' initiative has elevated behavioral health as a chronic disease prevention priority, positioning mental health and addiction treatment as central to national health strategy rather than peripheral. The data release occurs earlier than historical practice, signaling SAMHSA's commitment to rapid, data-driven policymaking. For therapists, this matters because federal epidemiological data directly influences state Medicaid funding, SAMHSA block grant allocations, and insurance company network decisions about which providers and service types to prioritize. When SAMHSA identifies a population with high unmet need—such as young adults with serious mental illness or adolescents with anxiety—states and payers respond by expanding coverage, increasing reimbursement rates, or loosening prior authorization requirements for those populations.
What you should do
Review the 2025 NSDUH data on your state's specific prevalence rates (available on SAMHSA's website by state) and cross-reference with your current patient population demographics; if your caseload skews older or lower-acuity than state prevalence data suggests, you may be missing high-need referral sources or underserving young adults where demand is highest.
Monitor your state Medicaid agency and your state's mental health authority for funding announcements over the next 6-12 months; SAMHSA block grant allocations informed by this data will drive state priorities, and states may expand coverage or increase reimbursement for services targeting young adults (18-25) or adolescents with anxiety and depression.
If you treat substance use disorders, update your clinical protocols and marketing materials to reflect the shift from opioid-focused to marijuana use disorder as the most prevalent drug use disorder; this may affect your patient intake questions, treatment planning, and referral partnerships.
Document your capacity to serve high-acuity populations (serious mental illness, suicidality, self-harm); the data shows 6.9% of adults and 12.1% of young adults have serious mental illness, and payers will increasingly prioritize providers with demonstrated competency in these areas when making network decisions.
Prepare for potential changes to prior authorization and documentation requirements if your state or payers adjust policies based on this data; if your state identifies unmet need in a particular population or diagnosis, expect payers to either loosen restrictions (to increase access) or tighten them (to manage costs), so stay alert to state Medicaid and insurance commissioner announcements.
Notable excerpts
During the past two decades, over 1.5 million lives have been lost to drug overdose and suicide, and many millions more have struggled with mental illness and addiction and their related health, social, and economic impacts.
In 2025, nearly 45 million Americans, 15.3% of people 12 years or older, met diagnostic criteria for a substance use disorder in the past year.
About 1 in 5 adults 18 years or older (20.6%; 54.6 million) had any mental illness (AMI) in the past year.
Among adolescents aged 12 to 17, prevalence for all key indicators declined between 2021 and 2025. This included declines in major depressive episode, serious thoughts of suicide, making a suicide plan, and suicide attempt in the past year.
View full source text
Policy changes drive denial patterns
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.
Related policy changes
STAT+: Trump administration quietly picks Timothy Westlake to lead mental health agency
SAMHSA leadership directly impacts federal funding streams, clinical guidance, and regulatory priorities that affect therapists nationwide. Westlake's background in addiction policy signals potential shifts in how SAMHSA allocates resources and develops clinical standards.
[OK] HB1911: Mental health; definitions; 988 Suicide and Crisis Lifeline System; administrative structure; evaluation; workforce retention; trust fund; telecommunication fee; maximization of federal funding; effective date.
This bill addresses the operational backbone of Oklahoma's 988 system with emphasis on workforce stability and federal funding leverage. For therapists, stable 988 infrastructure and workforce retention means more reliable crisis response for clients and potential partnership opportunities. The federal funding maximization language suggests the state is actively pursuing SAMHSA grants and other federal resources.
[OK] HB4092: 988 Mental Health Lifeline; terms; Department of Mental Health and Substance Abuse Services; suicide prevention and crisis service activities; performance and clinical standards; promulgation of rules; 988 Lifeline Revolving Fund; purpose; funding; enforcement; effective date.
While this bill primarily affects crisis centers and 988 infrastructure rather than direct therapy practice, it signals state investment in crisis services that may create referral pathways and reduce emergency department burden for therapists' clients. The funding mechanism and performance standards could influence how crisis services coordinate with outpatient mental health providers.
HHS clears 2 peer support programs for federal foster care funding
This expands federal funding pathways for peer support-based interventions in child welfare and family services. Therapists working in family-based treatment, substance use, or child welfare may see increased referrals or partnership opportunities as states adopt these programs, though direct reimbursement impact is limited.